washington post medicare

News

Medicare, drugs and weight loss

Medicare, Medicaid plan to experiment with covering weight loss drugs

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially benefiting millions of Americans struggling with obesity.

Reuters on MSN · 4d

US plans Medicare, Medicaid coverage for weight-loss drugs, Washington Post reports

The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington Post reported on Friday, citing documents from the Centers for Medicare and Medicaid Services.

Econostrum on MSN · 4d

Medicare May Soon Cover Weight Loss Drugs in Bold New Pilot Plan

The Trump administration is preparing a five-year pilot program that could allow Medicare and Medicaid to cover expensive GLP-1 weight loss drugs such as Ozempic, Wegovy, Mounjaro and Zepbound. If implemented,

4don MSN

A Medicare experiment could change who gets Ozempic

A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.

4don MSN

Trump’s Weight-Loss Experiment Could Aid Lilly, Novo. Cost Is Still a Problem.

The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.

6don MSN

Washington Post editorial slams Obama judge for blocking 'fair and square' GOP defunding of Planned Parenthood

The Washington Post editorial board argued a federal judge's ruling against congressional Medicaid restrictions on abortion ...

Becker's ASC6h

CMS pilot could ease GLP-1 access for Medicare, Medicaid patients

GLP‑1 receptor agonists are widely recognized for aiding weight loss and controlling blood sugar, but access remains limited — especially for Medicare and Medicaid patients. That might change with a ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results